TGFB2 and neoplasm: Although TGFβ2 specifically increased the pool of STP cancer cells in culture, as expected, it did not enhance the tumor progression when the cells were transplanted either subcutaneously (Fig. 5d) or intracranially (Fig. 5e), as TGFβ2 did not increase the number of LTP tumor-initiating cancer stem cells.